A simple continuous wave near-infrared algorithm for estimating local hemoglobin oxygen saturation in tissue (%StO 2 ) is described using single depth attenuation measurements at 680, 720, 760, and 800 nm. Second derivative spectroscopy was used to reduce light scattering effects, chromophores with constant absorption, baseline/instrumentation drift, and movement artifacts. Unlike previous second derivative methods which focused primarily on measuring deoxyhemoglobin concentration; a wide 40 nm wavelength gap used for calculating second derivative attenuation significantly improved sensitivity to oxyhemoglobin absorption. Scaled second derivative attenuation at 720 nm was correlated to in vitro hemoglobin oxygen saturation to generate a %StO 2 calibration curve. The calibration curve was insensitive to total hemoglobin, optical path length, and optical scattering. Measurement error due to normal levels of carboxyhemoglobin, methemoglobin, and water absorption were less than 10 %StO 2 units. Severe methemoglobinemia or edema combined with low blood volume could cause StO 2 errors to exceed 10 StO 2 units. Both a broadband and commercial four-wavelength spectrometer (InSpectra™) measured %StO 2 . The InSpectra tissue spectrometer readily detected limb ischemia on 26 human volunteers for hand, forearm, and leg muscles. A strong linear correlation, r 2 Ͼ0.93, between StO 2 and microvascular %SO 2 was observed for isolated animal hind limb, kidney, and heart.
Introduction
Noninvasive methods to measure oxygen transport and consumption in vivo have been, and continue to be, vital to the development of ideas in physiology and pathophysiology. 1 Optical methods are probably the least invasive and have the most potential use in a wide range of biological systems, as witnessed by the rapid development and ubiquity of pulse oximetry for measuring arterial oxygen saturation. Measuring deeper into tissue to obtain values for tissue oxygen delivery and oxygen saturation merely requires using longer wavelengths of light, such as those from 700 to 1300 nm used in near infrared spectroscopy ͑NIRS͒. 2 However, complications arise due to the scattering of light by tissue, and the overlapping absorbance spectra of the chromophores. 3 In vivo NIRS instruments use reflectance probes to measure scattered light re-emitted at a 20-50 mm distance from where the light emits into the tissue. 4 -12 The source-detector separation ͑probe spacing͒ influences light penetration depth and traversed distance ͑optical path length͒ within tissue. 13 Detected light photons encounter multiple scattering events in tissue resulting in an optical path length which exceeds the probe spacing distance, 14 varies with tissue scattering and absorption properties, 15 and is generally unknown. Therefore, in order to relate light signals to a hemoglobin or tissue chromophore measurement, NIRS tissue spectrometers must compensate for how an indeterminate and variable optical path length affects the measured light attenuation signal. In vivo NIRS's goal is to provide a reliable and accurate noninvasive quantification of oxyhemoglobin concentration ͓HbO 2 ͔, deoxyhemoglobin concentration ͓HHb͔, total hemoglobin concentration ͓HbO 2 ͔ϩ͓HHb͔, and/or tissue hemoglobin oxygen saturation ͓HbO 2 ͔/(͓HbO 2 ͔ϩ͓HHb͔).
Using estimates for the increase in optical path length beyond probe spacing, known as the differential path length factor, continuous wave ͑cw͒ spectrometers measure changes in the attenuation of 2-6 wavelengths of light, allowing algorithms based on the modified Beer-Lambert Law 4 to provide good estimates of tissue HHb and HbO 2 concentration change ͑⌬M͒. Additionally, measured changes in HHb and HbO 2 tissue concentration during physiological manipulation-for example, head tilting, 16 venous occlusion, 17 arterial occlusion, 18 and slow 19 or rapid changes 20 in the inspired oxygen fraction allows calculating the hemoglobin flow into tissue, rate of oxygen removal from hemoglobin, and the oxygenation state of hemoglobin entering specific compartments. Suitable calculations, with relatively few a priori assumptions, can be used to measure physiological parameters such as blood venous saturation, 16, 17 flow, 18, 20 blood volume, 19 and tissue oxygen consumption. 18, 21 Ultimately the goal of tissue NIRS is to measure absolute chromophore concentrations with accuracy not limited to optical path length or tissue scattering assumptions, such as being predictable and/or constant. The difficulty in quantifying NIRS signals has led to the development of different NIRS measurement methods. 22 Time resolved spectroscopy ͑TRS͒ instruments use pulsed lasers with synchronized detection in order to resolve the amount of time that launched photons remain in tissue in picoseconds, before being detected. 23 Phase modulated spectroscopy ͑PMS͒ instruments modulate the intensity of emitted light at a megahertz frequency in order to relate a phase shift between emitted and detected signals to the average amount of time, and hence distance, that photons travel within tissue. 24 Spatially resolved spectroscopy ͑SRS͒ instruments measure an attenuated light signal at multiple probe spacing distances, in order to solve tissue absorption using an assumed or calibrated value for tissue transport scattering coefficient ( s Ј). 25, 26 Variants of the SRS method exist. One method combines PMS and SRS in order to directly measure s Ј and solve for tissue absorption. 27 The TRS, PMS, and SRS methods require use of equations from diffusion theory to derive an estimate of the tissue absorption coefficient, a . [23] [24] [25] [26] [27] Significant absorbers can be determined after the tissue absorption coefficient is known for the wavelengths of emitted light. One method not requiring diffusion theory estimates of a involves a multiple distance cerebral signal precalibrated to a weighted measurement of arterial and jugular vein blood hemoglobin oxygen saturation. 28 For this case the difference in detected light between a 3 and 4 cm probe spacing is assumed to provide a cerebral attenuation signal independent of overlying extracranial tissues. 29 Although all these methods yield apparent values for tissue chromophore quantification, there have been relatively few attempts to compare and/or cross-validate one against another. The mean values of resting hemoglobin oxygen saturation in tissue can vary between methods; direct comparisons sometimes, 30 but not always 31 give similar readings. Measurement errors can result from approximations inherent in applying the diffusion theory estimates of a to heterogeneous tissue, an in vivo derived calibration set for which actual tissue hemoglobin oxygen saturation is unknown or total hemoglobin ͑Hbt͒ and optical path length influence the measurement signal. 32 An alternative approach to NIRS tissue chromophore quantification has therefore been to apply derivative spectroscopy to multiwavelength data, acquired by conventional cw NIRS techniques. Derivative spectroscopy is used to determine chemical compositions in biological fluids. [33] [34] [35] [36] With regard to in vivo tissue spectroscopy, a first derivative transformation of canine saggital sinus optical density spectra was empirically gathered to obtain linear regression coefficients for predicting venous hemoglobin oxygen saturation (SvO 2 ). 37 The gap segment for calculating a first differential was 1 nm, with no wavelength numbers skipped. Although the first derivative technique can remove baseline shifts from optical density spectra, it cannot remove sloping or tilting due to changes in wavelength dependent scattering, s Ј , either over time or upon movement of the measurement probe to different tissue sites. There is no evidence that the first derivative calibration equation presented could be applied to tissue sites other than the canine cerebral model that was used.
Therefore second derivative spectroscopy was chosen as it removes both baseline offset and linear slope from optical density attenuation spectra. Baseline offset refers to an arbitrary attenuation magnitude that can vary depending upon whether the spectrometer device is photometrically calibrated, whether detection gain remains fixed during measurements and/or the extent of scattering attenuation. Wavelengthdependent scatter provides a sloping bias. In tissue, shorter wavelength light has a smaller mean path between scattering events (1/ s Ј) that results in a higher scattering attenuation.
This wavelength-dependent scattering attenuation gradually decreases with increasing wavelength and can be approximated as being linear within a 650-900 nm wavelength region. 25,38 -40 Unlike attenuation spectra, second derivative attenuation spectra are centered to zero when absorption is zero since scattering features, having constant or weak attenuation change for the wavelength interval, are removed. Deoxyhemoglobin absorption provides a significantly nonzero second derivative attenuation spectra ͑near 760 nm͒ which can quantify cerebral deoxyhemoglobin concentration. [41] [42] [43] The HHb quantification method used multilinear regression to fit an acquired in vivo second derivative attenuation spectrum with the pure component spectra of HHb and water. The second derivative calculation used a third order polynomial fit to four adjacent wavelength attenuation measurements and then evaluated the second derivative of the polynomial for the shortest wavelength. The wavelength gap interval used to calculate the second derivative, which in this case was 1 nm, resulted in a minimal contribution of oxyhemoglobin to the measured tissue spectrum.
The goal of this study is to introduce a ''wide gap'' 40 nm second derivative spectroscopic method for quantifying hemoglobin oxygen saturation in tissue, or StO 2 . A wavelength gap significantly larger than 1 nm is required to amplify the spectral contribution of oxyhemoglobin absorption to an acquired in vivo attenuation spectrum. Although wavelength gaps shorter than 40 nm can be used for this method, a 40 nm gap provided maximum sensitivity to oxyhemoglobin concentration ͑reference Fig. 1͒ and resulted in fewer required measurement wavelengths. Maximum sensitivity to HbO 2 provides better measurement reproducibility whereas fewer wavelengths allow simplification of spectrometer design. This method provides a scaled second derivative attenuation spectrum; the wide gap used contains spectral regions that are sensitive to both oxyhemoglobin and deoxyhemoglobin concentration and allows quantification of hemoglobin oxygen saturation with four wavelengths: 680, 720, 760, and 800 nm. Unlike the previously mentioned first derivative method, it is anticipated that the proposed wide gap second derivative method provides an empirical calibration relationship, which can be applied across a variety of tissues exhibiting different scattering characteristics. This is particularly important when performing noncerebral measurements where optical scattering properties of the tissue are more likely to vary, such as in the forearm and leg. 25 A measurement method insensitive to optical scattering additionally allows an in vitro calibration relationship to be utilized where the scattering properties of the simulated tissue could be dissimilar to in vivo tissue.
Ease of use, cost effectiveness, and portability are vital if NIRS spectrometers are to find widespread application in physiological or clinical research. The wide gap second derivative technique presented does not require any solution to diffusion theory equations in order to derive its measurement, but merely requires a one-time empirical calibration such as in vitro hemoglobin at known oxygen saturation levels. The equipment used needs to be marginally more complex with two extra wavelengths than the readily portable Runman 44 ͑NIM Inc., Philadelphia, PA͒ and OMRON 45 ͑OMRON Ltd. Inc., Tokyo, Japan͒ spectrometers.
To assess the validity of the described method, StO 2 measurement performance was tested in a variety of systems: standard theoretical models of light transport in absorbing and scattering media; isolated blood tissue phantoms; isolated blood-perfused animal organs with minimal oxygen consumption; and healthy human volunteers with induced limb ischemia. The measurement error resulting from abnormal levels of carboxyhemoglobin and methemoglobin was also characterized.
Materials and Methods

StO 2 Measurement Equipment
Two spectrometer designs were used during the course of this study. Both designs used a closed cell polyethylene foam light scattering calibrator, Plastazote® LD 45 ͑Zotefoams Inc, Walton, KY͒, to capture reference light intensity for sampled light at each wavelength prior to placing a reflectance probe on the tissue measurement sites. Reference intensities were collected before each experiment and stored for subsequent attenuation measurements.
A first full spectrum spectrometer, Biospectrometer-NB ͑Hutchinson Technology Inc, Hutchinson, MN͒, consisted of a stabilized 25 W tungsten halogen light source and a reflective grating charged-coupled device ͑CCD͒ array photodetector providing wavelength measurements of 550-1000 nm with an increment of approximately 0.5 nm. Six 400 m glassreceiving fibers were coupled to the grating in a slit pattern to achieve a bandwidth resolution of 15 nm full width half maximum ͑FWHM͒. A Windows notebook computer was interfaced to custom software allowing data acquisition of StO 2 and sample spectrum signals were block averaged and updated every 5 s or less. The software provided autoclock rate adjustments and dark measurements for optical signals in the 680-800 nm range. Fiber optic probes, 3 m in length, used numerous 200 or 400 m glass optical send fibers to provide tissue illumination for probe spacings of 8 and 15 mm. Known transmission peaks of didymium glass calibrated the CCD array pixels to a corresponding wavelength prior to each experiment.
A second commercially available spectrometer, InSpectra™ Tissue Spectrometer Model 325 ͑Hutchinson Technology Inc, Hutchinson, MN͒, provided tissue attenuation measurements at four discrete wavelengths: 680, 720, 760, and 800 nm. Figure 2 details the optical components within the InSpectra tissue spectrometer. To exclude ambient light from the detected signal, four light emitting diodes ͑LEDs͒ were simultaneously pulsed on 760 Hz for 10 s at a drive current near 2 A. The photomultiplier tube ͑PMT͒ detection signal passed through an analog filter circuit that isolated and integrated the 760 Hz LED pulse signal. At 48 Hz, the integrated analog signal was converted to a digital signal representing ambient compensated light intensity. To minimize instrument drift, such as time-and temperature-dependent changes in LED output, PMT sensitivity, and dark signal offset, the digital count signal was subdivided into three controlled time intervals that were sequentially and continuously repeated.
• During the first interval of 0.1 s, the LEDs were off to provide an average dark intensity signal (I D ).
• For the second interval of 0.9 s, the shutter vane of Fig.  2͑a͒ passed light from the feedback optical path ͓L2 of Fig. 2͑a͔͒ to provide an average feedback intensity signal (I F ). An average reference feedback signal (I Fref ) was measured 5 min after powering on the instrument. Simultaneously, an average reference sample intensity was obtained using the polyethylene foam light scattering calibrator.
• During a third interval of 2.5 s, the shutter vane of Fig.  2͑a͒ passed light from the sample optical path ͓L1 of Fig. 2͑a͔͒ to provide an average sample signal (I S ).
At an update rate of 3.5 s, the drift compensated sample light signal (I DC ) was obtained as follows:
All four send fibers were coupled to a 1000 m, 30 cm length plastic optical fiber ͓MX of Fig. 2͑b͔͒ to mix the dis- Fig. 1 A 40 nm wavelength gap was used to amplify the contribution of HbO 2 concentration to a 720 nm second derivative optical attenuation measurement (2D 720 ). The wider wavelength gap spans the nonlinear region of published HbO 2 absorbance. 51 As the wavelength gap increases beyond 1 nm, 2D 720 rapidly increases in magnitude and begins to plateau near 40 nm.
crete light wavelengths prior to being launched into the measurement sample. Probe spacings of 12, 15, 20, and 25 mm were used. Several InSpectra spectrometer design methods 46 -50 were used to meet accuracy and usage requirements. The dual beam signal stabilization design and method 46 was of primary importance since each LED and PMT can have unique time and temperature drift characteristics. Providing a continuous drift compensation signal measured with the same light source and detectors used for StO 2 measurements limits StO 2 drift, measured 24 h after an initial reference intensity measurement, to Ϯ2 StO 2 units. Mixing the discrete light sources into one optical beam with the plastic mixer fiber 47 prior to illuminating tissue removes any path length bias from having the discrete sources separated and located directly on tissue. This feature is important because when probe spacing is narrowed, say from 25 to 3 mm, a 0.4 mm center-to-center separation of optical fibers becomes a larger percentage of the probe spacing, which correlates directly to optical path length. With random orientation of the source fiber directly on the measurement sample, the blood phantom as detailed in Sec. 2.3 and Fig. 3͑configuration A͒, observed probe-to-probe variability was near 10 StO 2 units with a 25 mm probe and 30 StO 2 units with a 3 mm probe. With homogenous mixing, probe-to-probe variability for all spacings of 3 mm or greater was found to be less than 3 StO 2 units. Wavelengths of homogeneous emitted light are more evenly absorbed by local surface structures, such as moles or hairs on skin, resulting in less StO 2 change as the probe is moved along the tissue. Other design aspects either relate to the StO 2 algorithm method 48 ͑fully described in Sec. 2.2͒ or pertain to instrument use. The InSpectra automatically senses when a probe is correctly placed on the foam calibrator. 49 A second derivative method for sensing total amount of hemoglobin 50 is used to determine when a probe is placed on blood containing tissue. The total hemoglobin amount measurement and ambient light signal via a photodiode ͓PD of Fig. 2͑a͔͒ prevent false StO 2 readings when the probe is not correctly placed on tissue.
StO 2 Algorithm
Tissue attenuation ͑A͒ measurements were calculated as log ͑reference intensity/sample intensity͒ for each measured Detection side optical components: L1 and L2 are aspheric collimating lenses, L3 is a plano convex condensing lens, SV is a stepper motor with a shaft mounted shutter vane, M1 is a 99% reflecting mirror, M2 is a combining mirror which transmits 99% of L1 light and reflects 1% of M1 light, M3, M4, M5, and M6 are, respectively, 800, 760, 720, and 680 nm dichroic mirrors, F1, F2, F3, and F4 are 10 nm FWHM interference filters for respective 800, 760, 720, and 680 nm center wavelengths, F5 is a 600 nm shortpass filter, PMT is photomultiplier tube, and PD is photodiode. (b) Removable probe optical components: SF is a sample light ferrule encompassing the receive optical fiber, RF is a 3-m-long 400-m-diameter glass optical receive fiber, FF is a feedback light ferrule encompassing a 200-m-diameter glass optical fiber, AT is a mixture of TiO 2 and epoxy which attenuates and mixes the LED light, LED1, LED2, LED3, and LED4 are respective 680, 720, 760, and 800 nm light emitting diodes coupled to 400 m glass optical fibers, MX is a 30-cm-long 1500 m plastic optical fiber which couples and mixes light from the four fiber coupled LEDs, J1 is an operator removable optical/electrical connector, J2 is an optical fiber splice housing, and J3 is the probe distal tip which mounts to tissue with a polyethylene foam adhesive backed patient interface (not shown).
Fig. 3
Schematic for the isolated blood circuit used to calibrate and test StO 2 measurement equipment. Configuration A represents the dual layer flow cell used to generate a calibration curve relating scaled 2D 720 to blood hemoglobin oxygen saturation, test StO 2 reproducibility among multiple instruments, and test StO 2 sensitivity to variable hemoglobin concentration and blood layer thickness. Configuration B represents a hollow flow cell used to contain a mixture of blood and Intralipid for testing StO 2 sensitivity to probe spacing, scattering changes, and water concentration. In configuration C, isolated blood perfused organs with inhibited oxygen consumption were used to characterize StO 2 performance in different tissues.
wavelength. At a fixed wavelength gap interval, the second derivative of attenuation (2D) was obtained at each wavelength ͑͒ nm using an algebraic simplification of the difference between two first derivative attenuation ͑D͒ measurements calculated at a similar gap interval:
A wavelength gap of 40 nm was used to calculate the second derivative attenuation at two wavelengths, 720 and 760 nm. These two second derivative attenuation signals are related to the four measured attenuation wavelengths as follows:
2D 760 ϭA 800 Ϫ2A 760 ϩA 720 . ͑7͒
For each tissue spectrum measurement a scaled 2D 720 value was used to predict tissue %StO 2 from a predetermined empirical calibration relationship:
An in vitro model of human blood flowing over a fixed scattering layer was used to relate scaled 2D 720 spectrum measurements to co-oximeter %SO 2 in order to create the empirical calibration curve ͑further detail provided in Sec. 2.3͒.
%StO 2 Equipment Calibration and Reproducibility
Scaled 2D 720 from Eq. ͑8͒ empirically correlated to blood hemoglobin oxygen saturation (%SO 2 ), measured with an IL 482 Co-Oximeter ͑Instrumentation Laboratory of Lexington, MA͒, using an isolated blood circuit coupled to a custom dual layer flow cell apparatus ͓Fig. 3͑configuration A͔͒.
The blood circuit ͑Fig. 3͒ consisted of a Minimax™ Hardshell Reservoir 1316 and Minimax™ Fiber Oxygenator 3381 ͑Medtronic, Minneapolis, MN͒ connected to a peristaltic pump and controlled temperature water bath to maintain a normothermic, 37.0Ϯ0.5°C, blood flow of 300 mL/min. Blood pH was maintained to 7.40Ϯ0.05 with 8 wt % sodium bicarbonate as needed. A custom flow cell, to mimic bloodperfused tissue, interfaced the optical probes between the 1 4 inch tubing which carried blood between the outlet port of the membrane oxygenator and the return port of the reservoir. A stopcock valve fitting placed between the flow cell outlet and reservoir return allowed syringe sampling of blood for cooximeter %SO 2 measurements.
The dual layer flow cell apparatus distributed the blood within the optical path of the measurement probes and provided a variable thickness of blood flowing over a block of LD45 Plastazote foam of sufficient volume to contain all emitted light paths. A top plastic film layer, 0.05 mm Mylar®D ͑DuPont Teijin Films, Hopewell, VA͒, separated flowing blood from contacting the measurement probes while a similar bottom plastic film separated the blood from the foam scattering material. Top and bottom plastic plates, housing the two plastic film layers and forming a sealed piston-like pressure vessel, were moved relative to each other in order to manipulate blood thickness and achieve signal attenuation close to blood perfused arm tissue measured with a 25 mm probe. In the absence of the flowing blood, the flow cell apparatus provides signal attenuation close to adipose tissue.
Human blood, 8.5 g/dL Hbt, flowing through the isolated blood circuit was equilibrated to variable concentrations of O 2 entering the membrane oxygenator. At 23 separate blood equilibrium conditions, spanning near 0-99 %SO 2 with increments near 5 SO 2 units, scaled 2D 720 ͓Eq. ͑8͔͒ measurements were paired with co-oximeter %SO 2 in order to model a calibration curve to an average spectral relationship. The IN-TERP1 function of Matlab® ͑The Mathworks Inc., Natick, MA͒ was used to fit and interpolate the calibration data ͑not shown͒ to provide a lookup table matching scaled 2D 720 to %StO 2 for all StO 2 values ranging from 0 to 99% with an increment of 1%.
A single calibration curve lookup table was developed and was common to all probe spacings used, from 8 to 25 mm. To account for spectral bandwidth effects, separate calibration tables were developed for both the full spectrum ͑Biospectrometer-NB͒ and discrete wavelength ͑InSpectra͒ spectrometer designs. The calibration curves were developed using first run prototypes of the InSpectra and Biospectrometer designs. Spectrometers and probes providing the results of this study were not used to develop the calibration curves.
Four InSpectra spectrometers with 12, 15, 20, and 25 mm probes were tested using 10 U/mL heparinized human blood, 9.5 and 7.0 g/dL Hbt, within the previously described isolated blood circuit apparatus ͓Fig. 3͑configuration A͔͒. Gas cylinders having 5% CO 2 , 0-21% O 2 , and the balance N 2 were used to equilibrate blood hemoglobin oxygen saturation to 12 randomly selected target levels at both total hemoglobin concentrations. At each test condition, four paired readings of co-oximeter %SO 2 and spectrometer %StO 2 were obtained. This human blood study was conducted by the Mayo Clinic Center for Applied Vascular Biology and Intervention at Rochester, MN within the guidance of Good Laboratory Practice for NonClinical Laboratory Studies, 21 CFR Part 58.
%StO 2 Performance in Simulated Tissue
Since hemoglobin and myoglobin have similar absorbance spectra, no attempt was made to distinguish between myoglobin and hemoglobin contributions to the in vitro and modeled data. The influence of total hemoglobin concentration, probe spacing with a variable optical path length, tissue optical scattering properties, and background water absorption were investigated using four simulated tissue models.
A pure hemoglobin theoretical model was used to test the inherent robustness of the algorithm method to total hemoglobin concentration and optical path length in a nonscattering absorbing medium. The model utilized the Lambert-Beer equation, which relates optical attenuation at a specific wavelength (A ) to path length distance ͑I͒, an absorbers concentration ͑C͒, and the absorber's absorption coefficient ( a ):
A ϭ a CI.
͑9͒
For Hbt, ranging from 0.05 to 0.50 mM, path lengths, ranging from 1 to 10 cm, and %SO 2 , ranging from 0 to 96%, the second derivative attenuation values at wavelengths of 720 and 760 nm ͓Eqs. ͑6͒ and ͑7͔͒ were calculated using published absorption coefficients for HbO 2 and HHb. 51 At each wavelength, the coefficients were summed and linearly weighted according to the modeled Hbt and %SO 2 conditions. The scaled 2D 720 value ͓Eq. ͑8͔͒ was calculated for each modeled input and represented the spectral measurement sensitive to %SO 2 .
A second in vitro blood model was performed to determine the effect of variable total hemoglobin concentration and blood volume ͑thickness͒ on StO 2 accuracy within a scattering environment. A 25 mm probe coupled to an InSpectra spectrometer was attached to the dual layer flow cell and an isolated blood circuit apparatus previously described ͓Fig. 3͑configuration A͔͒. StO 2 error relative to paired IL 482 CoOximeter %SO 2 measurements were recorded for bovine blood layer thicknesses of 0.8, 1.4, and 2.0 mm at total hemoglobin concentrations of 12 and 6 g/dL. Additionally, 720 and 760 nm second derivative attenuation and attenuation at 680, 720, 760, and 800 nm were recorded for each thickness and Hbt level.
A third in vitro blood model was used to determine how changes in the background scattering attenuation and water concentration might affect StO 2 accuracy for different probe spacings. The model consisted of isolated bovine blood, having intact red blood cells, diluted to 0.1 mM Hbt concentration with isotonic saline and 0, 0.2, 0.4, 0.6, and 0.8 wt % concentrations of Intralipid ͑Fresenius Kabi Clayton L.P., Clayton, NC͒. Four InSpectra spectrometers attached to 12, 15, 20, and 25 mm probes were used to measure changes in StO 2 as the Intralipid solution was incrementally added to the blood. The hollow flow cell of the previously described isolated blood circuit ͓Fig. 3͑configuration B͔͒ was used. Additionally, experiments involved 0.1 mM bovine hemoglobin, 0.4 wt % Intralipid, isotonic saline, and variable amounts of water and deuterium oxide. Deuterium oxide (D 2 O) has previously been used to adjust water concentration of tissue phantoms. 52 Four spectrometers having 12, 15, 20, and 25 mm probes were used to measure StO 2 accuracy at high, low, and middle range %SO 2 targets for the Intralipid/blood solutions with 70% and near 100% background water concentration. Prior to Intralipid measurements, 800 mL of bovine blood equivalent to 5 g/dL Hbt was pumped through the isolated blood circuit apparatus and the inlet gas pO 2 was adjusted until a target %SO 2 equilibrium was obtained and measured with an IL 682 Co-Oximeter. With the inlet gas pO 2 held constant, a portion of the blood was removed and replaced with calculated amounts of 20 wt % Intralipid, deionized water, deuterium oxide and sodium chloride. The molecular weight of hemoglobin was assumed to be 64 000 for all dilution calculations. The pH of the Intralipid/blood mixture was then adjusted to within 0.02 units of the starting bovine blood pH so the %SO 2 of the Intralipid/blood mixture could be assumed equivalent to the previously measured whole blood %SO 2 value. A fourth theoretical model was used to determine how changes in background water concentration might influence StO 2 accuracy for possible combinations of water and total hemoglobin concentration representative of different in vivo tissues. A single layer infinite slab diffusion theory equation 53 was used to create computer simulated tissue attenuation ͑A͒ spectra at variable inputs of a tissue absorption coefficient ( a ), a scattering coefficient ( s Ј) and a probe spacing ͑͒.
This model was previously used to evaluate NIRS algorithm performance 41, 51 and has the form:
͑10͒
For this single layer tissue model, the tissue absorbance coefficient ( a ) was estimated from absorbers thought to have the most significant spectral contribution for the %StO 2 algorithm wavelength region, 680-800 nm. Within this region, water has a nonlinear spectral contribution that is amplified due to its high concentration in tissue, 70 wt % 52 or 43 M considering lean tissue density of 1.1 kg/L. 54 Although fat has a lipid specific absorption peak near 930 nm, for this study it is assumed to have an effect similar to water, considering adipose tissue is 20% water. 52 The upper range of Hbt values modeled, 0.10-0.20 mM, is consistent with lean resting gastrocnemius muscle measured with a NIRS phase resolved spectrometer. 55 The optical scattering profile examined ͑Fig. 4͒ is for 1 wt % Intralipid. 56 concentration changed from 70% to 100%, the calibration data provided a best fit to the high StO 2 25 mm 0.1 mM Intralipid/blood empirical data obtained at near 100% water concentration. With the calibration held constant, the water and hemoglobin concentration was then varied to determine predicted %SO 2 values relative to the known input %SO 2 value. The difference between the predicted %SO 2 output and %SO 2 input represented the predicted %StO 2 measurement error at concentration combinations of Hbt and water.
Dyshemoglobin Effects
An InSpectra spectrometer coupled to a 25 mm probe was connected to the isolated blood circuit apparatus ͓Fig. 3͑con-figuration A͔͒. Bovine blood, 12Ϯ1 g/dL Hbt and 10 U/mL heparin, was primed into the circuit. In multiple 60 mL syringes, 14 mL of blood was mixed with 46 mL of carbon monoxide for 30 min to produce near 100% carboxyhemoglobin ͑COHb͒. During the 30 min period, the syringe gas space was expelled and replaced two to three times. Capped syringes were horizontally positioned to provide maximum contact area between the blood and gas layers. Five minutes after adding a 14 mL COHb sample to the blood, five paired readings of spectrometer %StO 2 and co-oximeter %SO 2 and %COHb were recorded. Methemoglobin was less than 1% for all measurements. After a low %SO 2 equilibrium experiment, the blood was purged and the circuit was primed with fresh blood in order to complete a similar high %SO 2 experiment.
Likewise, 0.5 mL doses of isotonic sodium nitrite solution were added stepwise to fresh blood, allowing %StO 2 error measurements at variable levels of methemoglobin ͑MetHb͒. COHb remained less than one percent for all methemoglobin equilibrium conditions. An IL 682 Co-Oximeter was used to obtain all %SO 2 , %COHb, and %MetHb measurements.
Isolated Blood-Perfused Canine Hind Limb and Porcine Organs
Isolated canine hind limb experiments were completed (n ϭ2) at Utah Biomedical Test Laboratory ͑Salt Lake City, UT͒ in accordance with Good Laboratory Practice for NonClinical Studies, 21 CFR Part 58. The Guide for the Care and Use of Laboratory Animals: DHHS, PHS, Revised 1985, was used for animal husbandry before and during the testing period.
The canine hind limb was surgically removed and kept viable by connection of femoral vein and artery cannulae to a normothermic ͑37Ϯ1°C͒ isolated blood circuit with a blood pump and membrane oxygenator as described 58 ͓also reference Fig. 3͑configuration C͔͒. Blood pH was maintained between 7.1 and 7.45 with additions of 8 wt % sodium bicarbonate.
Isolated porcine heart and kidney protocols, nϭ6 and n ϭ2, respectively, were approved by the University of Minnesota Animal Use Committee, in accordance with established guidelines for the treatment of laboratory animals.
Isolated potassium chloride arrested porcine hearts had a blood inlet cannula inserted in the brachiocephalic artery, while venous blood was allowed to outflow from a drain tube inserted through the base of the right atrium. A triple lumen pulmonary artery catheter was placed in the coronary sinus to facilitate venous blood sampling. The heart was clamped over a hollow reservoir draining back to a Minimax™ Hardshell Reservoir 1316 and Fiber Oxygenator 3381 ͓Fig. 3͑configu-ration C͔͒. A centrifugal pump ͑Medtronic BP-50 Biopump®, Minneapolis, MN͒ maintained an average perfusion pressure of 80 mm Hg. Potassium cyanide, 15 mg/mL, in 10 mL doses was infused as needed to inhibit tissue oxygen consumption in order to equilibrate the arterial and venous hemoglobin oxygen saturations to a difference of 5 %SO 2 units or less. The oxygen ratio within the gas flow to the membrane oxygenator was varied to adjust arterial hemoglobin oxygen saturation within a range of 5%-99%. An IL 482 Co-Oximeter provided organ inflow (SaO 2 ) and outflow (SvO 2 ) blood hemoglobin oxygen saturation measurements that were paired with 8 mm probe %StO 2 measurements at middle, upper, and lower left ventricle locations. If the paired SaO 2 and SvO 2 differences were greater than five %SO 2 units, the readings were not used, and additional cyanide was added through the arterial tubing sample port.
In two isolated porcine heart experiments, the kidney was harvested and similarly perfused using a bifurcated arterial line connected to two separate cannulae. Venous outflow from the kidney was gravity fed to a blood reservoir. The same 8 mm probe and full spectrum spectrometer ͑Biospectro-meter-NB͒ was used to obtain the heart and kidney %StO 2 measurements.
Human Volunteers with Induced Limb Ischemia
This study received approval from the United Hospital ͑St. Paul, MN͒ Institutional Review Board and was conducted and monitored in accordance with recognized Good Clinical Practices, 21 CFR parts 50, 54, 56, and 812.
Twenty-six volunteers, aged 27-56 years ͑meanϭ37.5 and SDϭϮ7.3 years͒, consented to participate. Individuals having a body mass index 59 of у30 were excluded from the study. Single unpaired StO 2 measurements were sequentially obtained on the subject's thenar eminence, a 12 mm probe, dorsal compartment of the forearm, a 20 mm probe, and the tibialis anterior muscle, 25 mm probe, at baseline, ischemia, and recovery. Baseline measurements were obtained with the subject in a supine position after 5 min of resting stabilization. Ischemia was induced via inflation of a pneumatic tourniquet 50 mm Hg above systolic blood pressure. Subjects having systolic pressures greater than 140 mm Hg were excluded from participation. Prior to ischemia, both the test leg and arm were elevated for 2 min to facilitate venous blood drainage. The test arm was also exercised using a graspable squeeze ball during the first 30 s of cuff ischemia. Upper extremity measurements began 2.5 min after induction of the cuff pressure. Lower extremity ischemia measurements began 5 min after cuff inflation. Inflation time did not exceed 15 min for either extremity. The mean StO 2 value and its standard deviation were computed for each probe depth and tissue bed at each of the three blood flow state conditions.
Statistical Methods
Scatter plots and linear regression models were used to describe correlations between %StO 2 and reference %SO 2 measurements. The squared Pearson correlation coefficient 60 was used to describe the degree of regression model fit. Squaring the correlation coefficient and multiplying it by 100 describes the percent variability in observed StO 2 , explained by changes in the reference %SO 2 measurement. Statistical significance was determined at p valueϽ0.05. StO 2 error is expressed as the difference between measured or predicted %StO 2 and the reference %SO 2 method. Variability in human tissue measurements were expressed using mean %StO 2 with one standard deviation of the measurement population.
For the human isolated blood study, a repeated measurement analysis of variance test method 61 was used to determine significant mean effects. Repeating %StO 2 measurements, four spectrometers and four replicate measurements per spectrometer, at each %SO 2 target, provided better estimates of how total hemoglobin concentration and probe spacing affected StO 2 measurements. Root mean square error for all paired spectrometer StO 2 and co-oximeter SO 2 measurements was calculated as follows:
where nϭnumber of measurements.
Results and Discussion
StO 2 Measurement Equipment
The Biospectrometer-NB spectrometer design acquired broadband attenuation spectra and allowed optimization and minimization of the wavelengths needed for a StO 2 measurement ͑detailed in Sec. 3.2͒. With an algorithm method defined ͓Eq. ͑8͔͒, the InSpectra spectrometer was developed specifically to improve ease of use and reduce operator induced measurement errors.
%StO 2 Algorithm
A plot of published pure component HbO 2 and HHb absorption spectra 51 and second derivative absorption transformations using both narrow ͑1 nm͒ and wide ͑40 nm͒ wavelength gaps ͑Fig. 5͒ reveals the reasons for choosing an algorithm incorporating a 40 nm gap second derivative transformation. The absorbance profile of HbO 2 ͓Fig. 5͑a͔͒ is nonlinear within the 680-760 nm wavelength region. With a wide 40 nm gap, the HbO 2 second derivative at 720 nm is approaching maximal amplitude ͓Fig. 5͑b͔͒, whereas the corresponding 1 nm gap amplitude ͓Fig. 5͑b͔͒ is effectively zero. Therefore the larger 40 nm gap HbO 2 spectral contribution allows a more precise estimate of %SO 2 . The 760 nm HHb specific 40 nm gap second derivative amplitude ͓Fig. 5͑d͔͒, being larger than the corresponding 1 nm gap amplitude ͓Fig. 5͑c͔͒, also provides noise tolerance. The 1 nm gap spectra-required curve fitting of the absorption spectra to provide visually presentable second derivative spectra, while the 40 nm gap second derivative spectra required no absorption smoothing. The problems associated with noise, especially when measuring HbO 2 with 1 nm gap amplitudes, has been discussed elsewhere. 62 Similar spectral results were found ͑Fig. 6͒ when comparing blood attenuation spectra near 0 and 100 %SO 2 measured with the previously described isolated blood circuit apparatus ͓Fig. 3͑configuration A͔͒.
Second derivative blood attenuation spectra is sensitive not only to hemoglobin oxygen saturation but also total hemoglobin concentration ͑Hbt͒ and probe spacing ͑Fig. 7͒. Increasing the total hemoglobin ͓Figs. 7͑a͒ and 7͑b͔͒ or the probe spacing ͓Figs. 7͑a͒ and 7͑c͔͒ results in an increased signal amplitude. Therefore, a ratio of two second derivative attenuation measurements was used in order to provide a %SO 2 specific measurement that would be inherently robust to optical path length and Hbt ͑Table I͒.
The 760 nm second derivative attenuation is ideally suited for this method because it exhibits maximal amplitude change with variable %SO 2 , at fixed Hbt and path length, and has no spectral contribution from HbO 2 . With a prerequisite 760 nm second derivative wavelength, the 720 nm second derivative wavelength was chosen as the second wavelength for its relatively close proximity to 760 nm and its sensitivity to both HbO 2 and HHb. Since the 40 nm gap interval equaled the distance between the numerator and denominator second derivative wavelengths, a reduction from six to four measurement wavelengths occurred ͓see Eqs. ͑6͒ and ͑7͔͒, simplifying spectrometer design. Although a similar reduction of wavelengths would result from using an 800 nm second derivative measurement relative to 760 nm, the 720 nm scaled point was chosen because of its larger and more varied second derivative amplitude with respect to %SO 2 ͓Figs. 5͑f͒ and 6͑f͔͒.
%StO 2 Equipment Calibration and Reproducibility
Several approaches were possible for developing a calibration curve relating scaled 2D 720 measurements ͓Eq. ͑8͔͒ to hemoglobin oxygen saturation in tissue. Currently no measurement standard exists for measuring tissue hemoglobin oxygen satu- ration. An approach using an in vivo calibration would involve assumptions regarding how the NIRS signal best represented a balance between invasively measured arterial and venous %SO 2 near the measured tissue site. Therefore, an in vitro calibration method was adopted because it provided a controlled test environment for characterizing repeatability of StO 2 measurements among the multiple spectrometer designs manufactured.
One in vitro method reviewed involved immersing a 5 mm probe in diluted whole blood, 5-12 g/dL Hbt, having sufficient volume to contain nearly all optical path lengths. This method was used to demonstrate the variability of second derivative amplitudes versus %SO 2 , Hbt and probe spacing ͑Fig. 7͒, but was not used to develop the depicted calibration curves ͓Fig. 8͑a͔͒ because the test environment provided too much signal attenuation with probes greater than 10 mm spacing. Although dilution of total hemoglobin significantly below 5 g/dL would reduce absorption and allow long path length measurements, the blood scattering properties would be significantly reduced as the red blood cell count decreased.
Intralipid emulsion solution has been used to provide a constant scattering environment to dilute Hbt into assumed tissue levels, р1 g/dL. 63 However, blood co-oximeters, the current standard for blood %SO 2 , have limited accuracy below 5 g/dL Hbt, even before considering the possible interference from Intralipid. Although it is possible to derive a calculated saturation (%SO 2 c) from blood pH, pO 2 , and temperature without Intralipid interference, some discrepancies between %SO 2 measured directly with an IL482 Co- Oximeter and %SO 2 c derived from an IL blood gas analyzer have been noted by the authors. Usually %SO 2 c is generally 10 units higher across the full range with whole bovine blood. Because of this discrepancy, it was uncertain whether Hill type equations 64 for predicting %SO 2 from pH, pO 2 and temperature could be accurately extrapolated to all possible %SO 2 values at hemoglobin concentrations below the normal physiologic range of blood.
Therefore a dual layer flow cell and isolated blood circuit was used ͓Fig. 3͑configuration A͒ and detailed in Sec. 2.3͔ for controlling hemoglobin oxygen saturation of an approximate 1 mm thick layer of blood flowing above a constant scattering layer of polyethylene foam. This enabled optimal co-oximetry measurements, allowing blood full range %SO 2 to be accurately defined and the possible confounding effects of carboxyhemoglobin and methemoglobin to be investigated. The two-layer model additionally allowed all probe spacings of this study to be correlated to co-oximeter %SO 2 .
An alternative calibration could simply use mathematical modeling such as a diffusion theory equation as described in Sec. 2.4. In such a case the absorption coefficient data should be empirically measured with the same optical equipment used for measuring %StO 2 to account for how center wavelength and bandwidth resolution influences a calibration curve.
Results of the co-oximeter human blood correlation study indicated a strong linear correlation of %StO 2 to %SO 2 for both the four wavelength ͑InSpectra͒ and full spectrum ͑Biospectrometer-NB͒ spectrometers ͓Figs. 8͑b͒ and 8͑c͔͒. Total hemoglobin concentration, 7.0 and 9.5 g/dL, was not a significant source of measurement variability (pϭ0.993). Multiple measurements using four InSpectra systems revealed that the root mean square errors of individual measurements were 1.6 StO 2 units within a 70%-99% range and 2.9 StO 2 units for a 0-70% range. The calibration curves of Fig. 8͑a͒ are nearly vertical at low StO 2 and horizontal at high StO 2 . Thus at low StO 2 a small change in scaled 2D 720 causes larger StO 2 change when compared to high StO 2 . This spectral relationship implies that StO 2 error at low StO 2 might be drastically worse than at high StO 2 . However, Fig. 7 shows that second derivative amplitude approaches zero at high StO 2 and is significantly large at low StO 2 . Therefore scaled 2D 720 is more precise at low StO 2 since measurement errors, due to noise for example, are a smaller proportion of the 720 and 760 nm second derivative amplitudes. The more precisely measured 2D 720 spectral measurement at low StO 2 offsets its higher spectral sensitivity to StO 2 thus providing a 0-70% root-mean-square ͑rms͒ error only about two times higher than the 70%-100% error.
Significant error sources affecting StO 2 reproducibility for the human blood correlation study include center wavelength and bandwidth variation since a common calibration curve was used for all devices, nonlinearity of light detection system relative to optical density, uncorrected drift in system light detection and illumination efficiency, as well as shot noise inherent in the low light level detection circuitry.
StO 2 Performance in Simulated Tissue
Since no in vivo %StO 2 standard exists, in vitro tests combined with theoretical mathematical models provided a means to examine the sensitivity of the StO 2 measurement method to changes in total hemoglobin concentration, optical path length, optical scattering, and water concentration.
The isolated blood circuit in vitro model ͓Fig. 3͑configu-ration A͔͒ consisted of two primary absorbers, HbO 2 and HHb, combined with a polyethylene foam background scat- Fig. 8 Spectrometer stored %StO 2 calibration curves and resulting correlation to co-oximeter human blood %SO 2 using the dual layer flow cell apparatus [ Fig. 3(configuration A)] . (a) Empirically calibrated relationship between %StO 2 and measured second derivative attenuation ratio for the two-spectrometer designs utilized in this study. The average spectral relationship was obtained at 8.5 g/dL Hbt with four spectrometers. Data used to generate the calibration curves are not shown. (b) Correlation of four previously calibrated InSpectra spectrometers to co-oximeter %SO 2 using 12, 15, 20, and 25 mm probe spacings. The 384 measurements were equally divided among human blood at 9.5Ϯ0.5 and 7.0Ϯ0.5 g/dL Hbt. All measurement points were obtained using a common calibration curve. (c) Crossinstrument correlation of one previously calibrated Biospectrometer-NB spectrometer to co-oximeter %SO 2 using one 20 mm probe to obtain 47 bovine blood measurements at 10 g/dL Hbt.
tering environment. Despite changes in the relative attenuation ͓Fig. 9͑a͔͒ and second derivatives ͓Fig. 9͑b͔͒, the measured saturation remained independent ͓Fig. 9͑c͔͒ of blood path length or thickness and hemoglobin concentration. These results suggest that, in a scattering environment, the 2D 720 measurement ͓Eq. ͑8͔͒ is inherently robust to changes in Hbt and path length as found in the nonscattering Beer-Lambert model results ͑Table I͒.
Intralipid results of Fig. 10 show that despite significant changes in Intralipid concentration, 0-0.8 wt %, a less than ten StO 2 unit change was observed for a wide range of probe spacings, 12-25 mm. Light scattering ( s Ј) of Intralipid solution is linearly related to Intralipid concentration and is estimated to be 8 cm Ϫ1 at 800 nm for the maximum 0.8 wt % Intralipid concentration tested. 56 Red blood cell concentration ͑hematocrit͒ also linearly relates to scattering and provides a s Ј of about 2 cm Ϫ1 at 800 nm for 0.1 mM total hemoglobin, near 2% hematocrit. 65 At 0.8 wt % Intralipid and 0.1 mM Hbt the effective scattering of the Intralipid/blood solution ( s Ј) is estimated as 10 cm Ϫ1 at 800 nm assuming that the overall scattering coefficient is a linear sum of its individual components. The range of optical scattering tested, s Ј of 10 cm Ϫ1 or less, agrees with in vivo estimates for human tissues inclusive of muscle; about 8 -10 cm Ϫ1 at 800 nm measured with TRS on human legs and arms 25 and about 3-5 cm Ϫ1 at 800 nm on human forearm measured with SRS combined with PMS. 38 For the 0.15 mM Hbt 0.4 wt % Intralipid test condition, it was observed that the 20 and 25 mm probe light intensity signals were approaching the threshold limit at which the monitor stops displaying StO 2 . Loss of signal prevented some 20 and 25 mm probe measurements ͓see Fig. 10͑b͔͒ . Errors in dark signal measurement result in a nonlinear light detection signal, which can create greater StO 2 measurement error near the low signal threshold limit and could explain the wider range of StO 2 shown in Fig. 10͑b͒ . The experimental results demonstrate that the StO 2 second derivative algorithm method is insensitive to large changes in optical scattering. Insensitivity of StO 2 to optical path length can also be concluded since the 12, 15, 20, and 25 mm probes, each having significantly different optical path lengths, gave StO 2 readings within a range Additional Intralipid/blood experiments were performed in order to independently validate StO 2 accuracy in a homogenous blood scattering media different then the dual layer flow cell used to develop the StO 2 calibration curve. For these 0.1 mM total hemoglobin experiments ͓Fig. 11͑b͔͒, 0.4 wt % Intralipid was chosen to provide higher detected light intensity for a 25 mm probe spacing in order to better characterize StO 2 error due to background water absorption. Overall s Ј is estimated to be 6 cm Ϫ1 at 800 nm. Whereas the blood layer of the dual layer flow cell contains a high level of water ͑near 99%͒, the segregated polyethylene foam layer has no water. Due to the nature of the calibration system, the precise amount of water included in the spectral measurements used to develop the initial StO 2 calibration relationship is unknown. The results of Fig. 11͑b͒ indicate that at near 100% water concentration, StO 2 error due to background water absorption is greater at higher levels of StO 2 and approaches Ϫ20 StO 2 units near 100% hemoglobin oxygen saturation. At normal levels of muscle water concentration ͑near 70%͒ the maximum StO 2 error is estimated to be Ϫ10 StO 2 at 100% hemoglobin oxygen saturation. Figure 11 shows that the amount of StO 2 measurement error due to variable water concentration is dependent upon the amount of water relative to the amount of total hemoglobin. Highest StO 2 measurement errors occur at 0.05 mM total hemoglobin when water concentration exceeds 70%. Lean muscle tissue has a hemoglobin concentration range of 0.1-0.2 mM and a water concentration near 70%. Tissue comprising of adipose and muscle can have a hemoglobin concentration approaching 0.05 mM with water concentration limited to 50% or less. 55,66 -68 StO 2 inaccuracy due to normal levels of tissue water appears to be less than ten absolute SO 2 units.
At tissue hemoglobin concentrations of 0.1 mM or less, edema might cause a significant negative bias to StO 2 measurements provided the added water occurs within the scattering media, in and adjacent to cells. A free space water layer accumulation, devoid of cellular bodies which cause scattering, is not represented in the measurement model and is expected to have less influence on StO 2 accuracy since multiple Fig. 3(configuration B) ]. Four InSpectra spectrometers with 12, 15, 20, and 25 mm probe spacings were used to obtain the four plotted measurements common to the level of %SO 2 tested. At 5% SO 2 and near 100% SO 2 actual StO 2 is estimated from a standard human blood dissociation curve for the measured solution pH, solution temperature and oxygenator outlet gas pO 2 . For all other intermediate levels of %SO 2 , actual %SO 2 is estimated from co-oximeter measurements obtained with 5 g/dL blood flowing in the isolated blood circuit prior to diluting the blood to a 0.1 mM Hbt and adding D 2 O and Intralipid. All dilution liquids were adjusted to 0.9 wt % NaCl. The oxygenator gas outlet pO 2 remained constant before and after hemoglobin dilution and the Intralipid/blood mixture pH was adjusted to match the blood pH corresponding to the co-oximeter measurement sample. StO 2 error represents measured StO 2 minus estimated %SO 2 .
light scattering events within the water layer are required to amplify the spectral contribution of water.
Dyshemoglobin Effects
A second derivative transformation of attenuation spectra has commonly been used to limit interference from chromophores having constant background absorption. Wavelength regions are selected where the chromophore of interest has nonlinear absorption and possible confounders have near linear or constant absorption. Within 680-800 nm, the absorption spectrum of carboxyhemoglobin is more linear and less steep than methemoglobin, 69 which explains why the %StO 2 algorithm is less sensitive to carboxyhemoglobin interference compared to methemoglobin ͑Fig. 12͒.
The normal reference range for blood methemoglobin and carboxyhemoglobin is less than 2% total hemoglobin. 70 Within this reference range, carboxyhemoglobin and methemoglobin induced %StO 2 error was limited to near ϩ2 and ϩ4 StO 2 units, respectively. For smokers, the carboxyhemoglobin reference range is 2%-20%, 70 which results in a possible ϩ6 StO 2 unit bias.
Cyanosis is a clinical symptom associated with blood methemoglobin levels exceeding 10%. 70 At high StO 2 , elevated methemoglobin produced a limited bias near ϩ10 StO 2 units, whereas at low StO 2 , the bias linearly increased as methemoglobin concentration increased. Methemoglobinemia could confound the ability to diagnose low hemoglobin oxygen saturation in tissue. However, we conclude that under the vast majority of conditions, the levels of these hemoglobin derivatives will not contribute significant errors to the measured oxygen saturation.
Isolated Blood-Perfused Canine Hind Limb and Porcine Organs
Isolated blood perfused organs provided a living tissue model in which to access the adequacy of the in vitro calibration method and the repeatability of %StO 2 measurements among tissues having different optical absorption and scattering characteristics.
The reflected intensity signals used to derive the %StO 2 measurements are thought to emerge from arterioles, capillaries, and venules 44 and the average traversed depth of the detected photons is approximately one half the probe spacing distance. 13 The second derivative attenuation signal measured at 720 and 760 nm increases in amplitude with an increase in Hbt ͑Fig. 7͒. Therefore, it is reasonable to assume that the %StO 2 signal is weighted towards the micro vascular structures producing the largest second derivative attenuation, and thus represent the largest overall contribution to blood volume within the measured tissue space. It is generally assumed that tissue hemoglobin oxygen saturation will be nearer that of the venous system, rather than the arterial system. However, since the distribution of blood volume within arterioles, capillaries and venules can change with limb position ͑venous pooling͒ and vascular resistance, it is difficult to represent %StO 2 as a constant weighted measurement of SaO 2 and SvO 2 for the tissue being measured. Therefore potassium cyanide was used to inhibit oxygen consumption of the isolated organs in order to minimize the %SO 2 gradient within the tissue micro vasculature, and hence reduce any artifacts introduced to the test by having to estimate accurately the exact compartment͑s͒ measured by NIRS.
With the SaO 2 and SvO 2 gradient held to within a range of 0-5 %SO 2 at a constant %SaO 2 , it was assumed that a weighted average of paired SaO 2 and SvO 2 measurements would provide an estimate of the micro vascular blood %SO 2 to an uncertainty of Ϯ2.5 %SO 2 units. The correlation plots of %StO 2 versus the estimated microvascular %SO 2 , defined as (0.33SaO 2 ϩ0.67SvO 2 )/2, indicate a linear correlation generally within 10 %SO 2 units of the identity line ͑Fig. 13͒. The observed correlation was similar among the canine hind limb, porcine heart, and kidney tissue. In all tissues Ͼ93% of StO 2 variability was caused by changes in microvascular %SO 2 . Further, the y intercept was between ϩ9 and ϩ14 StO 2 units and the mean difference between regression line and identity was ϩ3.3, ϩ10.1, and ϩ6.7 StO 2 units for respective hind limb, heart, and kidney.
The calibration curve representing the full spectrum spectrometers used for the isolated animal tissue measurements ͓Fig. 8͑c͔͒ suggests that some of the positive y intercept might be attributable to the calibration curve stored within the devices. This could arise from spectral bandwidth variations between the devices used to create the calibration relationship and the devices used for this study. The depicted calibration relationship ͓Fig. 8͑c͔͒ is for a 20 mm probe and diffusion theory analysis results ͑not shown͒ indicate an upward pivoting of the calibration slope for a shallow probe spacing. This is particularly noticeable in the 8 mm probe isolated kidney data ͓Fig. 13͑c͔͒. In addition to the errors we predict from diffusion theory analysis, nonhomogeneous perfusion and distribution of cyanide might result in microvascular regions where %SO 2 is outside the assumed uncertainty limit. Lack of homogeneous cyanide distribution might create a lower than expected StO 2 due to localized high levels of oxygen consumption resulting in lower venule %SO 2 . Further, regions of restricted flow might create longer delays between downward %SaO 2 adjustments and microvascular %SO 2 equilibration resulting in higher readings than anticipated. Nevertheless, despite these small errors, it is clear that an in vitro calibration based on our two-layer model can be applied successfully to measure %SO 2 in a range of in vivo situations.
Myoglobin ͑Mb͒ is another error source, as we calibrated %SO 2 solely to hemoglobin oxygen saturation. However, linear regression results ͓Figs. 13͑b͒ and 13͑c͔͒ demonstrate similar correlations of StO 2 to microvascular %SO 2 for both myoglobin and nonmyoglobin tissues ͑heart and kidney, respectively͒ using the same StO 2 measurement device. These results indicate that myoglobin does not significantly bias %StO 2 measurements. Myoglobin and hemoglobin have similar absorption profiles within the wavelength region measured, 680-800 nm. Considering the broad resolution of the StO 2 spectrometers utilized, 10-15 nm FWHM, and wide second derivative gap, it is apparent that the described StO 2 method and equipment cannot resolve the minor wavelength shifts that have been reported between HHb and Mb tissue spectra. 71 However, even if the spectrometer cannot distinguish between Mb and HHb, the fact remains that the in vivo measures were tested only against co-oximeter hemoglobin saturation values. Therefore, myoglobin saturation changes could be detected by the spectrometer; but be silent to the co-oximeter.
Proton nuclear magnetic resonance ͑NMR͒ spectroscopy has been used to measure exercising gastrocnemius myoglobin and hemoglobin NMR signals simultaneously with an NIRS relative hemoglobin measurement. 44 There is conflicting evidence as to whether Mb does change significantly during muscle exercise and as to whether the kinetics of NIRS hemoglobin signals may be more representative of Mb changes during cuff ischemia. 72 However, a recent modeling investigation suggests that myoglobin effects should not be discounted regarding the interpretation of NIRS derived hemoglobin signals in muscle. 73 
Human Volunteers with Induced Limb Ischemia
A study on healthy human limbs provided a means to characterize changes in StO 2 with induced ischemia. Since adipose tissue thickness can influence how the measurement signal is weighted toward muscle, a variety of probe spacings were used in an effort to provide the best balance between measurement depth and measurement precision. Excessively wide probe spacing on lean muscle would cause a low detected light intensity and reduce measurement precision. Conversely, excessively narrow probe spacing could result in the StO 2 measurement signal being derived solely from cutaneous and adipose tissues. As a guide for selecting probe spacing for a given population of test subjects, probe spacing design dimensions of at least two to three times the estimated sum of cutaneous and adipose thickness were chosen. Table II shows that the InSpectra spectrometer reliably detected decreases in tissue hemoglobin oxygen saturation induced by ischemia. The absolute change between baseline and ischemia, and between ischemia and recovery was found to be statistically significant for males and females for every probe and muscle combination ͑p valuesϽ0.01͒. The most likely explanation for the statistically significant differences in dorsal mean StO 2 measurements between males and females are differences in the thickness of the adipose tissue.
Conclusion
We describe a continuous wave algorithm for estimating hemoglobin oxygen saturation in tissue using single depth at- tenuation measurements at four wavelengths. The wide 40 nm gap second derivative algorithm ͓Eq. ͑8͔͒ and in vitro calibration method provides an %StO 2 measurement that can be applied across a variety of tissues and probe spacings with no measured or assumed values for optical path length or optical scattering. The measurement makes fewer assumptions and is technically simpler than other current methods for measuring absolute tissue oxygen saturation.
The StO 2 measurement method was insensitive to total hemoglobin concentration, optical path length, and optical scattering changes. Doubling hemoglobin concentration, blood thickness, probe spacing or optical scattering resulted in StO 2 changing р5 StO 2 units. Measurement error due to normal levels of tissue water, carboxyhemoglobin or methemoglobin was less than 10 StO 2 units. At low StO 2 , methemoglobinemia exceeding 5% total hemoglobin caused StO 2 errors to exceed 10 StO 2 units. Edema combined with low tissue blood volume could result in StO 2 errors exceeding 10 StO 2 units particularly at high %StO 2 levels. Across a full range of tissue hemoglobin oxygen saturation, StO 2 measurements readily detected hypoxia in isolated animal organs and ischemia in human limbs.
This work demonstrates that a single wide gap second derivative algorithm can usefully measure saturation in a range of different tissue types. For a given measurement location, the possible changes in tissue water content should not significantly influence observed StO 2 changes. However, as is the case with all NIRS algorithms, if the optical properties of the tissue are known in detail ͑e.g., water content, scattering͒ individualized tissue algorithms would lead to more precise absolute hemoglobin oxygen saturation measurements.
We anticipate that further optimization of calibration method and spectrometer design will improve StO 2 measurement performance. Meanwhile, research into how muscle StO 2 responds and relates to local and systemic physiological change is being investigated.
